Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0

作者：

Gao, Xiaoya ^{[1
,2
]}

机构：

[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China

[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China

来源：

FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷

关键词：

Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;

D O I：

10.3389/fnagi.2023.1247256

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页数：3

共 50 条

[41] Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease
Evans, Jonathan R.
Barker, Roger A.
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1249 - 1258
[42] The past, present, and future of disease-modifying therapies for Alzheimer's disease
Suzuki, Kazushi
Iwata, Atsushi
Iwatsubo, Takeshi
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2017, 93 (10): : 757 - 771
[43] Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors
Makoto Naoi
Wakako Maruyama
Masayo Shamoto-Nagai
Journal of Neural Transmission, 2022, 129 : 737 - 753
[44] Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors
Naoi, Makoto
Maruyama, Wakako
Shamoto-Nagai, Masayo
JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) : 737 - 753
[45] How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease?
Lenka, Abhishek
Jankovic, Joseph
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (02) : 107 - 122
[46] GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms
Schneider, Jay S. S.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
[47] The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer's Disease and Parkinson Disease
Gulcan, Hayrettin O.
Orhan, Ilkay E.
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (04) : 509 - 516
[48] Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease
Bateman, Randall J.
Klunk, William E.
NEUROTHERAPEUTICS, 2008, 5 (03) : 381 - 390
[49] The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers
Paoletti, Federico Paolini
Gaetani, Lorenzo
Parnetti, Lucilla
BIOMOLECULES, 2020, 10 (02)
[50] Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives
Imbimbo, Bruno P.
Lozupone, Madia
Watling, Mark
Panza, Francesco
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 919 - 933

← 1 2 3 4 5 →